Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Faroux

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Gastroenterologie Clinique Et Biologique|December 17, 1998
[Ischemic colitis after taking flutamide]J Barouk, M Doubremelle, R Faroux, et al.
Presse Medicale (Paris, France : 1983)|August 5, 1987
[Treatment of external pancreatic fistula by depot somatostatin]R Faroux, J F Bretagne, I Le Jean-Colin, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|January 1, 1989
[Surgical treatment of chronic pancreatitis. Indications and results. An experience of 246 cases]J P Campion, E Bardaxoglou, P Caillon, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1993
[Black esophagus. Three new cases]J Y Robert, J L Raoul, J F Bretagne, et al.
Radiology|August 1, 1988
Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastasesJ F Bretagne, J L Raoul, P Bourguet, et al.
Oncology|March 2, 2011
Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France: XELOX versus FOLFOX-6G Perrocheau, J Bennouna, M Ducreux, et al.
British Journal of Cancer|November 19, 2009
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancerT Conroy, M Hebbar, J Bennouna, et al.
Gastroenterologie Clinique Et Biologique|April 12, 2003
[Multicenter prospective study of prognostic factors of gastroduodenal ulcer hemorrhages. Reevaluation of clinical and endoscopic factors in the era of endoscopic hemostasis]A Bourienne, M Pagenault, D Heresbach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trialC Louvet, R Labianca, P Hammel, et al.
British Journal of Cancer|July 20, 2007
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancerJ-P Delord, J Bennouna, P Artru, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Gastroenterologie Clinique Et Biologique|December 17, 1998
[Ischemic colitis after taking flutamide]J Barouk, M Doubremelle, R Faroux, et al.
Presse Medicale (Paris, France : 1983)|August 5, 1987
[Treatment of external pancreatic fistula by depot somatostatin]R Faroux, J F Bretagne, I Le Jean-Colin, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|January 1, 1989
[Surgical treatment of chronic pancreatitis. Indications and results. An experience of 246 cases]J P Campion, E Bardaxoglou, P Caillon, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1993
[Black esophagus. Three new cases]J Y Robert, J L Raoul, J F Bretagne, et al.
Radiology|August 1, 1988
Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastasesJ F Bretagne, J L Raoul, P Bourguet, et al.
Oncology|March 2, 2011
Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France: XELOX versus FOLFOX-6G Perrocheau, J Bennouna, M Ducreux, et al.
British Journal of Cancer|November 19, 2009
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancerT Conroy, M Hebbar, J Bennouna, et al.
Gastroenterologie Clinique Et Biologique|April 12, 2003
[Multicenter prospective study of prognostic factors of gastroduodenal ulcer hemorrhages. Reevaluation of clinical and endoscopic factors in the era of endoscopic hemostasis]A Bourienne, M Pagenault, D Heresbach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trialC Louvet, R Labianca, P Hammel, et al.
British Journal of Cancer|July 20, 2007
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancerJ-P Delord, J Bennouna, P Artru, et al.
Pageof 3